GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (XCNQ:HEAL) » Definitions » Current Accrued Expense

Restart Life Sciences (XCNQ:HEAL) Current Accrued Expense : C$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Restart Life Sciences Current Accrued Expense?

Restart Life Sciences's Current Accrued Expense for the quarter that ended in Dec. 2024 was C$0.00 Mil.

Restart Life Sciences's quarterly Current Accrued Expense declined from Jun. 2024 (C$1.01 Mil) to Sep. 2024 (C$0.79 Mil) and declined from Sep. 2024 (C$0.79 Mil) to Dec. 2024 (C$0.00 Mil).


Restart Life Sciences Current Accrued Expense Historical Data

The historical data trend for Restart Life Sciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Current Accrued Expense Chart

Restart Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Restart Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.94 1.01 0.79 -

Restart Life Sciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Restart Life Sciences Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Restart Life Sciences Business Description

Traded in Other Exchanges
Address
700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).
Executives
Derek Lloyd Harry Ivany 10% Security Holder, Director, Senior Officer
Steven Feldman Director
William Rascan Director, Senior Officer

Restart Life Sciences Headlines

No Headlines